BME494 Sp2014 Dhatt: Difference between revisions
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
Globally, 227-285 million individuals have diabetes and about 90% of these individuals have Type II diabetes. In 2011, 1.4 million deaths occurred worldwide due to the result of diabetes making it the 8th leading cause of death. This number is estimated to double in the next 15 years, therefore, there is a need for a rapid diagnostic test. | Globally, 227-285 million individuals have diabetes and about 90% of these individuals have Type II diabetes. In 2011, 1.4 million deaths occurred worldwide due to the result of diabetes making it the 8th leading cause of death. This number is estimated to double in the next 15 years, therefore, there is a need for a rapid diagnostic test. | ||
Line 48: | Line 45: | ||
==Design of a New Device== | ==Design of a New Device== | ||
The device will be designed as a diagnostic tool for diabetes and the functionality of the genetic switch replicates that of an “AND” logic gate. The device will require two conditions to be true in order for an output to be produced. One condition is that IPTG must be present in the device’s environment. When IPTG is present, it will bind to the LacI repressor and allow for transcription to continue. The other condition is that glucose levels in the device’s environment must be low. Glucose levels affect production of cAMP inversely; when glucose levels are high, cAMP production decreases and when glucose levels are low, cAMP production increases. cAMP binds to catabolite activator protein (CAP_ to form the CAP-cAMP complex. For the complex, cAMP must be present and glucose levels must be low. This complex is the required input of the device. In the natural lac operon, the CAP-cAMP complex leads to activation of gene expression from the lac operon. If glucose is present, cAMP levels will be low and the host will metabolize glucose if lactose is present. | |||
<!-- Show a network/ circuit diagram of your device. Include a paragraph to explain how it works (e.g., how to switch the system from on to off and vice versa, and what happens to each component as the system switches between states) --> | <!-- Show a network/ circuit diagram of your device. Include a paragraph to explain how it works (e.g., how to switch the system from on to off and vice versa, and what happens to each component as the system switches between states) --> | ||
[[Image: | [[Image:BME494_Dhatt_AndGate.jpg|300px|AND gate logic gene toggle switch. IPTG and low glucose levels conditions must be met in order for GFP production]] | ||
[[Image:BME494_Dhatt_AndGateTable.jpg|300px|Table describing that both inputs are needed in order to produce an output]] | |||
Revision as of 14:02, 8 May 2014
My Profile Dr. Haynes OpenWetWare Previous Course Wiki Editing Help
Background & Proposed ApplicationBACKGROUND
The synthetic system modeled in the “Construction of a genetic toggle switch In Escherichia coli” uses two different states, an “on” state” and an “off” state (Gardner et all 2000). The classical system uses two repressor and two promoter pairs in which both repressors are inhibited by a different inducer, aTc and IPTG. The promoters were placed next to the repressor gene of the opposite pair. This system represents a bistable gene-regulatory network where only one promoter can be expressed at one time because the expression of one promoter repressed expression of the other promoter. The on-state of the cell was represented by placing a green fluorescent protein (GFP) transcription gene downstream of the on-state promoter.
Globally, 227-285 million individuals have diabetes and about 90% of these individuals have Type II diabetes. In 2011, 1.4 million deaths occurred worldwide due to the result of diabetes making it the 8th leading cause of death. This number is estimated to double in the next 15 years, therefore, there is a need for a rapid diagnostic test.
Design of a New DeviceThe device will be designed as a diagnostic tool for diabetes and the functionality of the genetic switch replicates that of an “AND” logic gate. The device will require two conditions to be true in order for an output to be produced. One condition is that IPTG must be present in the device’s environment. When IPTG is present, it will bind to the LacI repressor and allow for transcription to continue. The other condition is that glucose levels in the device’s environment must be low. Glucose levels affect production of cAMP inversely; when glucose levels are high, cAMP production decreases and when glucose levels are low, cAMP production increases. cAMP binds to catabolite activator protein (CAP_ to form the CAP-cAMP complex. For the complex, cAMP must be present and glucose levels must be low. This complex is the required input of the device. In the natural lac operon, the CAP-cAMP complex leads to activation of gene expression from the lac operon. If glucose is present, cAMP levels will be low and the host will metabolize glucose if lactose is present.
Building the New DeviceSYNTHETIC DNA LAYOUT
Testing the New DeviceLAC OPERON MODEL SIMULATION
Similarities:
Differences:
Human Practices
About the Designer
References[1] Full reference. [2] Full reference. [3] Full reference.
|